UNOG-NEWS WHO COVID-19- Treatments - Remdesivir 20NOV2020
/
3:08
/
MP4
/
231.7 MB

Edited News | WHO

UNOG-NEWS WHO COVID-19- Treatments - Remdesivir 20NOV2020

COVID-19: UN health agency issues conditional advice against using remdesivir

Patients with COVID-19 should not be given the antiviral drug remdesivir “regardless of disease severity”, the UN World Health Organization (WHO) said on Friday.

Nonetheless, describing its recommendation as “conditional”, as opposed to “strong”, WHO stressed that data from a global trial on the efficacy of remdesivir was inconclusive, and that further trials should continue into its use for more vulnerable patients.

“We recommend a conditional recommendation – I want to highlight that - against the use of remdesivir in hospitalised patients with COVID-19 regardless of disease severity,” said Dr Janet Diaz, Head of Clinical Care at WHO, during a virtual press conference in Geneva.

According to data from the WHO-led Solidarity trial which was then examined by a panel of international experts behind the recommendation, “possibly remdesivir can lead to 29 fewer deaths per 1,000 patients or up to 11 more deaths per 1000 patients”, Dr Diaz said. “So you can see that …the confidence interval are relatively large…there was no evidence that there was any important effect on mortality, on the need for mechanical ventilation or the time to clinical improvement.”

But this did “not prove” that the antiviral “had no benefit at all”, Dr Diaz insisted. “There could still be potential small benefit, maybe in a health sub-group which is why the panel also recommended continued trials, continued enrolment into clinical trials.”

The WHO official explained that this might be “severe patients versus critical patients” or whether the antiviral is used “early versus late”.

Dr Bram Rochwerg, who was among the experts advising WHO, noted that there would likely be regional “variations” in the use of remdesivir.

While a minority of people will still choose to use it, the majority would not, based on the available data, he said.

“There may be groups (who might benefit) and the data was a bit more of a close call, so that’s why we felt strongly that trials need to continue using remdesivir and studying remdesivir and looking to see if there are specific groups that might, that might benefit,” he said. “We were very explicit that we do believe that these studies need to continue (and) Solidarity is continuing.”

Although the remdesivir development mirrors similar attempts to use other antivirals against the new coronavirus, Dr Diaz said there was no reason to lose hope in the fight against COVID-19.

“I do think there is a tremendous global effort to investigate treatments. You know, I think a lot of interest was done upfront with the repurposed of drugs, repurposed antivirals, you know we saw that with other repurposed drugs such as hydroxychloroquine, lopinavir, and there was a big push to try to test these and they’ve been tested and unfortunately, we just haven’t, you know, the results haven’t been as promising as we had hoped. But I don’t want to forget that we do have one lifesaving drug and even though it’s a repurposed old, old drug dexamethasone, a corticosteroid, we do know that that does reduce mortality, save lives of patient with severe and critical so there is something.”

Latest data from WHO indicates that eight in 10 people infected with COVID report mild symptoms, Dr Diaz said.

“Since the beginning (of the pandemic)…about 80 per cent of people have, you know, mild disease, a proportion maybe moderate disease and then only a small proportion, a smaller proportion, 20 per cent go on to develop severe or critical disease, and critical disease is a small, small portion, it’s five per cent or less, and that is…and that seems to be kind of consistent I think through the literature so most patients do have, if they have mild disease, self-limiting disease, they get better on their own, their immune system kicks in and they get better.”

Nonetheless, there are reports of more “persistent longer-term symptoms”, Dr Diaz noted. “So even though they don’t get severe disease there can be some persistent symptoms that lasts longer than one would have hoped for.”

  1. SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “We recommend a conditional recommendation - so I want to highlight that, it’s a conditional recommendation - against the use of remdesivir in hospitalized patients - with COVID-19, regardless of disease severity.”
  2. SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “Possibly remdesivir can lead to 29 fewer deaths par 1,000 patients or up to 11 more deaths per 1,000 patients so you can see that this is, the confidence interval is a little bit large.”
  3. SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “It was not clear that, there was no evidence, that there was any important effect on mortality, on the need for mechanic ventilation or the time to clinical improvement.”
  4. SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “This did not prove that remdesivir does not have a benefit at all and that’s why it is a conditional recommendation, there can still be potential small benefit, maybe in a health sub-group, which is why the panel also recommended continued trials, continued enrolment into clinical trials.”
  5. SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “You know, is there a sub-group that may benefit more – such as severe patients versus critical patients. Is there a timing in disease that may benefit more - such as early versus late - and those are all considerations that are in the guidelines.”
  6. SOUNDBITE (English) — Dr Bram Rochwerg, practising ITU clinician and expert adviser for WHO-led Solidarity Trial: “There may be groups and the data was a bit more of a close call, so that’s why we felt strongly that trials need to continue using remdesivir and studying remdesivir and looking to see if there are specific groups that might, that might benefit. And as she said, we were very explicit that we do believe that these studies need to continue, Solidarity is continuing, so.”
  7. SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “I do think there is a tremendous global effort to investigate treatments. You know, I think a lot of interest was done upfront with the repurposed of drugs, repurposed antivirals, you know we saw that with other repurposed drugs such as hydroxychloroquine, lopinavir, and there was a big push to try to test these and they’ve been tested and unfortunately, we just haven’t, you know, the results haven’t been as promising as we had hoped. But I don’t want to, I don’t want to forget that we do have one lifesaving drug and even though it’s a repurposed old, old drug dexamethasone, a corticosteroid, we do know that that does reduce mortality, save lives of patient with severe and critical so there is something.”
  8. SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “Since the beginning, is that about 80 per cent of people have, you know, mild disease, a proportion maybe moderate disease and then only a small proportion, a smaller proportion, 20 per cent go on to develop severe or critical disease, and critical disease is a small, small portion, it’s five per cent or less, and that is…and that seems to be kind of consistent I think through the literature so most patients do have, if they have mild disease, self-limiting disease, they get better on their own, their immune system kicks in and they get better.”
  9. SOUNDBITE (English) — Dr Janet Diaz, Head of Clinical Care, WHO: “We do know that even patients with mild disease may have persistent longer-term symptoms. And that has been now described; so even though they don’t get severe disease there can be some persistent symptoms that lasts longer than one would have hoped for.”

Similar Stories

Gaza healthcare attacks – WHO

1

1

1

Edited News | WHO

Gaza healthcare attacks – WHO ENG FRA

The ongoing Israeli military offensive in Gaza City continues to overwhelm the war-torn enclave’s medical professionals, with four more hospitals forced to shut down this month alone, the UN World Health Organization said on Friday.

UN Report: Civilian detainees subjected to troubling patterns of torture and ill treatment since Russia’s full scale attack on Ukraine

1

1

1

Edited News | OHCHR , UNOG

UN Report: Civilian detainees subjected to troubling patterns of torture and ill treatment since Russia’s full scale attack on Ukraine ENG FRA

A UN Human Rights report released today details the dire situation of thousands of civilians detained since Russia’s full-scale armed attack on Ukraine in 2022. 

Sudan cholera update WHO - UNICEF

1

1

1

Edited News | WHO , UNICEF

Sudan cholera update WHO - UNICEF ENG FRA

Sudan war: Life-saving cholera vaccination campaign begins in Darfur

Amid the devastating war in Sudan, UN aid teams are overcoming major obstacles to curb a cholera outbreak claiming lives across the country, with young children particularly at risk.

Afghanistan earthquake response – UN Women 19 September 2025

2

1

2

Edited News , B-roll | UN WOMEN

Afghanistan earthquake response – UN Women 19 September 2025 ENG FRA

Women and girls still reeling from Afghanistan's recent deadly earthquake face even greater suffering rebuilding their lives and livelihoods without much more help from the international community, UN Women said on Friday.

UN report: Sudan crisis deepens amid rising civilian casualties - UN Human rights spokesperson Jeremy Laurence and OHCHR Sudan Representative Li Fung

1

1

1

Edited News | OHCHR , UNOG

UN report: Sudan crisis deepens amid rising civilian casualties - UN Human rights spokesperson Jeremy Laurence and OHCHR Sudan Representative Li Fung ENG FRA

Rising civilian casualties, growing ethnic violence and the grim humanitarian situation in Sudan underscore how the crisis there is deepening, according to a UN Human rights report published today.

'Not a Target' UN Geneva Protest - 18 September 2025

1

1

1

Edited News | UNITED NATIONS

'Not a Target' UN Geneva Protest - 18 September 2025 ENG FRA

United Nations agencies staff demonstrates on Place des Nations in Geneva to denounce the killing of their colleagues in Gaza.

WMO - World Water Monitor 18 September 2025

1

1

1

Edited News | WMO

WMO - World Water Monitor 18 September 2025 ENG FRA

The world’s water resources face growing pressure from climate change while emergencies related to the vital resource are increasingly impacting lives and livelihoods, the UN World Meteorological Organization (WMO) said on Thursday.

UN High Commissioner for Human Rights Volker Türk Remarks to HRC 60 Urgent debate

1

1

1

Edited News | OHCHR , UNOG

UN High Commissioner for Human Rights Volker Türk Remarks to HRC 60 Urgent debate ENG FRA

The UN High Commissioner for Human Rights Volker Türk addressed the Human Rights Council during a meeting on the Israeli strike on negotiators in Qatar on Tuesday. “Israel’s strike on negotiators in Doha on 9 September was a shocking breach of international law, an assault on regional peace and stability, and a blow against the integrity of mediation and negotiating processes around the world,” he said.

Gaza Al-Mawasi update - UNICEF

1

1

1

Edited News | UNICEF

Gaza Al-Mawasi update - UNICEF ENG FRA

Gaza: Thirsty and starving, war-battered families face ‘inhumane’ evacuation 

As bombs continue to fall on Gaza City as part of the intensifying Israeli military operation, families with starving children are being pushed southwards from one “hellscape” to another, the UN Children’s Fund (UNICEF) said on Tuesday.

UN Human Rights Spokesperson Elizabeth Throssell on DPRK

1

1

1

Edited News | OHCHR , UNOG

UN Human Rights Spokesperson Elizabeth Throssell on DPRK ENG FRA

New UN Human Rights report finds 10 years of increased suffering repression and fear

The UN Human Rights Office on Friday published a report on the human rights situation in the Democratic People's Republic of Korea (DPRK) since 2014. 

Afghanistan update - UNICEF UNHCR 12 September 2025

1

1

2

Edited News | UNICEF , UNHCR

Afghanistan update - UNICEF UNHCR 12 September 2025 ENG FRA

The ongoing humanitarian response to the devastating Afghanistan earthquake disaster continued on Friday, although essential services have been cut for operational reasons following reinforced Taliban restrictions on women working with the UN, the global body said.

UN High Commissioner for Human Rights report on DRC at the 60th Human Rights Council

1

1

1

Edited News | OHCHR , UNOG

UN High Commissioner for Human Rights report on DRC at the 60th Human Rights Council ENG FRA

Un nouveau rapport du Haut-Commissariat des Nations Unies aux droits de l'homme sur la République démocratique du Congo évoque le spectre de crimes de guerre et de crimes contre l'humanité dans le Nord et le Sud-Kivu.,